drugset / Trial / NCT04485585
A Study to Evaluate Drug-drug Interactions Between BR9006-1 and BR9006-2 in Healthy Male Volunteers.
NaSingle-groupOpen-labelTreatment
Summary
To evaluate the influence of BR9006-1 and BR9006-2 on pharmacokinetics, safety, and tolerability when administered separately or co-administered to healthy male volunteers.
Timeline
- Start
- 2020-07-20
- Primary completion
- 2020-08-16
- Completion
- 2020-08-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mirabegron | Other / unclassified | 50 mg | — |
| Subject | Tamsulosin | Other / unclassified | 0.2 mg | — |